MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Ankylosing Spondylitis

  1. Home
  2. Diseases
  3. Ankylosing Spondylitis
  4. Clinical Trials

Clinical Trials Related to Ankylosing Spondylitis

Related studies linked through entity extraction aliases.

NCT00207701

A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.

Status
COMPLETED
Phase
PHASE3

NCT00195819

Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis

Status
COMPLETED
Phase
PHASE3

NCT00195416

Study Investigating Enbrel Treatment for Ankylosing Spondylitis

Status
COMPLETED
Phase
N/A

NCT00133315

TNFalfa Blocking Treatment of Spondylarthropathies

Status
COMPLETED
Phase
PHASE4

NCT00126724

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT00085995

Progression of Spinal Fusion in Ankylosing Spondylitis

Status
COMPLETED
Phase
N/A

NCT00085644

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

Status
COMPLETED
Phase
PHASE3

NCT00081562

Genetics of Ankylosing Spondylitis

Status
COMPLETED
Phase
N/A

NCT00056849

Genetic Determinants of Ankylosing Spondylitis Severity

Status
COMPLETED
Phase
N/A

NCT00056719

Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study

Status
COMPLETED
Phase
N/A

NCT00004288

Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis

Status
COMPLETED
Phase
PHASE2

NCT00000416

Prevention of Arthritis-Related Work Disability

Status
COMPLETED
Phase
NA
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.